CBT

Cabot Corporation

Materials · USD

CBT

Price

$76.24

-0.06%

Cap

$4.0B

Earnings

4/4 beat

30d Trend

+0%

CBT
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range71%
58.3383.71

Upper half of range — momentum is positive

Analyst consensus (6 analysts)-3% to target
0 Strong Buy1 Buy4 Hold1 Sell0 Strong Sell

Target range: $54$85 (consensus: $73.75)

Consensus: Hold

Earnings history

Q1 2026

BEAT

1.53 vs 1.39

Q4 2025

BEAT

1.7 vs 1.69

Q3 2025

BEAT

1.9 vs 1.82

Q2 2025

BEAT

1.9 vs 1.86

VolatilityLow

Key macro factors

·

Weakened global economic growth and industrial/manufacturing production impacting demand for specialty chemicals in key end markets like automotive and construction.

·

Volatility in raw material prices, such as petrochemicals, and escalating energy costs, which directly affect production expenses and profit margins for specialty chemical companies.

·

Ongoing supply chain disruptions, geopolitical tensions (e.g., Middle East conflict), and evolving trade policies, influencing logistics, investment decisions, and international trade volumes.

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts, USA, providing a broad range of solutions to customers in key industries such as transportation, infrastructure, environment and consumer.

Next earnings:May 5, 2026

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

Cabot Corporation (CBT) — Brain47 AI Score 70/100 | Analysis